Variation of the antimicrobial susceptibility profiles of Burkholderia cepacia complex clonal isolates obtained from chronically infected cystic fibrosis patients: a five-year survey in the major Portuguese treatment center.
about
Potential of metabolomics to reveal Burkholderia cepacia complex pathogenesis and antibiotic resistanceGenomic expression analysis reveals strategies of Burkholderia cenocepacia to adapt to cystic fibrosis patients' airways and antimicrobial therapy.Regulation of Hfq mRNA and protein levels in Escherichia coli and Pseudomonas aeruginosa by the Burkholderia cenocepacia MtvR sRNASwimming motility in a longitudinal collection of clinical isolates of Burkholderia cepacia complex bacteria from people with cystic fibrosis.Burkholderia cenocepacia and Salmonella enterica ArnT proteins that transfer 4-amino-4-deoxy-l-arabinose to lipopolysaccharide share membrane topology and functional amino acids.Polyphasic characterisation of Burkholderia cepaciacomplex species isolated from children with cystic fibrosisAutophagy stimulation by rapamycin suppresses lung inflammation and infection by Burkholderia cenocepacia in a model of cystic fibrosis.Candidate Essential Genes in Burkholderia cenocepacia J2315 Identified by Genome-Wide TraDISLong-term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression alterations.Cell Wall Recycling-Linked Coregulation of AmpC and PenB β-Lactamases through ampD Mutations in Burkholderia cenocepacia.Ag(I) camphorimine complexes with antimicrobial activity towards clinically important bacteria and species of the Candida genus.SNaPBceBcon: a Practical Tool for Identification and Genotyping of Burkholderia cepacia and Burkholderia contaminansBurkholderia vaccines: are we moving forward?The Burkholderia cenocepacia OmpA-like protein BCAL2958: identification, characterization, and detection of anti-BCAL2958 antibodies in serum from B. cepacia complex-infected Cystic Fibrosis patients.Burkholderia cepacia Complex: Emerging Multihost Pathogens Equipped with a Wide Range of Virulence Factors and Determinants.Whole genome sequencing of bacteria in cystic fibrosis as a model for bacterial genome adaptation and evolution.Clinical and in vitro evidence for the antimicrobial therapy in Burkholderia cepacia complex infections.Burkholderia cenocepacia phenotypic clonal variation during a 3.5-year colonization in the lungs of a cystic fibrosis patient.Immune Recognition of the Epidemic Cystic Fibrosis Pathogen Burkholderia dolosa.Burkholderia cepacia Complex Regulation of Virulence Gene Expression: A Review.A rare case of community acquired Burkholderia cepacia infection presenting as pyopneumothorax in an immunocompetent individual.Short Palate, Lung, and Nasal Epithelial Clone 1 Has Antimicrobial and Antibiofilm Activities against the Burkholderia cepacia Complex.RETRACTED: MtvR is a global small noncoding regulatory RNA in Burkholderia cenocepacia.SNaPBcen: a novel and practical tool for genotyping Burkholderia cenocepaciaA putative lateral flagella of the cystic fibrosis pathogen Burkholderia dolosa regulates swimming motility and host cytokine production.Antibacterial activity of silver camphorimine coordination polymers.
P2860
Q26798603-DD1EB4ED-A4FD-4D1B-9029-BD0882DE2D1FQ34117003-890E2D25-49AA-40F3-864A-E2CCF40F184BQ35182348-79A49A51-5493-4447-9FD9-66F08B006C99Q35244339-841838E9-9CE7-41E2-AF3D-9097414185EAQ35647818-6EADD9FC-8F76-4AAB-A9C2-BE8E155636F4Q35905382-C665FBCD-7581-40C8-8C51-43E4A01A0936Q35985429-41B3043B-E1E9-47EF-B11F-833CA39EAC98Q36123634-6D7A87E9-DF6D-4A55-9DEF-9FF75D0525DCQ36158775-56D1CA1F-99C4-4C33-BFE3-DF8BBAFED4CCQ36290729-04CCC62B-08DC-4DD0-AFB8-C076E5D4A649Q36367084-13F5A8D2-E5AA-44F8-81D2-B9F778EE2C75Q36521306-36238542-1AF5-4585-930E-DD9662BD8618Q36587103-96473B9E-99F2-4428-878A-C9AFFA48EFD9Q37026632-8AC2B94C-48FA-4323-8736-291BDF1D4610Q37784697-2A3ABA2A-9AE3-4EE3-BD5E-EA9C2424070AQ38185756-52C967EF-4644-487D-A058-C7E010ADBB47Q38378454-995A921F-8D0E-4D79-AFAD-A5E32F1CC887Q38686620-37F67633-81CC-4CBB-B854-A13D5CD6758DQ38710198-BE651D98-C2BB-4B77-8040-55724A83009CQ39010188-C0A85728-DE50-4444-8FF5-A1CFD5E02C05Q39337593-C4BAD90D-91A2-45A6-8E8B-1BE6BDD342E0Q39560004-CEAF0906-D30E-4289-878D-D22D56D66A3AQ41763069-37A9DD92-22CB-4E26-89CE-B5A8C10C8C45Q42164433-F78704F8-4D32-4F89-8140-0B5C9777BEC5Q47653778-FD75A0FF-AD00-4D4E-A1C8-69249F939BC6Q54248545-42687B96-4DC6-4D09-B487-5AA22BBF9399
P2860
Variation of the antimicrobial susceptibility profiles of Burkholderia cepacia complex clonal isolates obtained from chronically infected cystic fibrosis patients: a five-year survey in the major Portuguese treatment center.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Variation of the antimicrobial ...... r Portuguese treatment center.
@en
Variation of the antimicrobial ...... r Portuguese treatment center.
@nl
type
label
Variation of the antimicrobial ...... r Portuguese treatment center.
@en
Variation of the antimicrobial ...... r Portuguese treatment center.
@nl
prefLabel
Variation of the antimicrobial ...... r Portuguese treatment center.
@en
Variation of the antimicrobial ...... r Portuguese treatment center.
@nl
P50
P1476
Variation of the antimicrobial ...... or Portuguese treatment center
@en
P2093
M C Barreto
M J Salgado
P2860
P2888
P304
P356
10.1007/S10096-008-0552-0
P577
2008-07-04T00:00:00Z